Overview
InVirtuoLabs is a Swiss biotechnology company that combines generative artificial intelligence with physics-based molecular simulations to accelerate the discovery of small-molecule therapeutics. The company's platform, InVirtuoGEN, explores vast chemical spaces to design and optimize novel drug candidates for metabolic, neurological, and rare diseases with high precision and reduced development costs.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.